Vitamodo School · Bundle 4: Antipsychiatry — The Critique Analyzed · Brochure 10 of 10 · Version 1.0
Andris Saulitis, MD
For those who: have worked through the preceding nine brochures of this bundle and want the working clinician's verdict — the synthesis the bundle has been arguing toward.
Not for those who: want a final position. The verdict is a working synthesis, open to revision, and meant to be put to work in specific clinical situations.
What this is — the clinical reality
This is the closing brochure of Bundle 4. The nine previous brochures have, between them, set out the question of whether mental illnesses are real, the institutional history of the asylum era, the Soviet misuse of psychiatry, the three founders of the antipsychiatric critique, the antidepressant debate, the overprescribing question, the patient voice and what the survivor movement got right, the open dialogue and alternative-models tradition, and the structural sociology of why the critique persists. Each brochure has tried to be analytical rather than apologetic — to hold the critique and the defence together in their specific arguments rather than collapsing into either pole.
This brochure is the working psychiatrist's verdict. After forty years of clinical practice, reading the critical literature in parallel with my own clinical work, and being corrected over and over by patients, colleagues, and the slow accumulation of evidence, this is the honest accounting I have arrived at: where the critique has been substantially right, where it has been substantially wrong, and what this means for the practice I have been doing and the practice I have been recommending to younger clinicians and to patients trying to make sense of psychiatric care.
A note before we go further. This is a verdict in the working sense, not a final pronouncement. Verdict in clinical practice means the best I can hold at present, knowing the evidence I have, expecting to be corrected by what comes next. The history of my own thinking on these questions has been a history of substantial corrections, most of them coming from patients, some from critical writers, some from the careful new evidence. The clinician who treats their current position as settled is not the clinician who continues to learn. This is a working verdict that I expect future versions of this brochure to revise.
A second note. This brochure is for the reader who has worked through the preceding nine. The arguments here will refer to specific positions developed earlier in the bundle. Reading this brochure alone, without the previous ones, will produce a flattened version of what is in fact a layered set of positions.
Three frames carry the verdict.
The first frame is where the critique has been right. The specific positions the antipsychiatric critique has held, in one form or another, across decades, that the discipline has been slow to absorb and that have proven substantially correct. I list these as positions, with brief acknowledgement of which thread of the critique pressed each most clearly.
The chemical-imbalance story — the public-facing explanation that depression is low serotonin and that the medication corrects it — was always weaker than its deployment in patient information and pharmaceutical advertising suggested. The careful critique pressed this point for decades. The Moncrieff 2022 meta-review is the most recent confirmation of what the careful clinical specialists had long understood and the patient-led literature had long argued. The story should not be told to patients in the form it has been told. The medications may still help; the explanation deserves better than this.